Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Get Free Report) insider Shane William Charles Kovacs sold 100,000 shares of Olema Pharmaceuticals stock in a transaction dated Thursday, January 15th. The stock was sold at an average price of $28.73, for a total value of $2,873,000.00. Following the sale, the insider directly owned 139,727 shares in the company, […]

Fate Therapeutics, Inc. (NASDAQ:FATE – Get Free Report) insider Cindy Tahl sold 10,589 shares of the firm’s stock in a transaction dated Friday, January 9th. The shares were sold at an average price of $1.06, for a total transaction of $11,224.34. Following the completion of the transaction, the insider directly owned 387,081 shares in the […]

Fate Therapeutics, Inc. (NASDAQ:FATE – Get Free Report) insider Cindy Tahl sold 10,589 shares of Fate Therapeutics stock in a transaction dated Friday, January 9th. The shares were sold at an average price of $1.06, for a total value of $11,224.34. Following the completion of the sale, the insider directly owned 387,081 shares in the […]

PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report) insider Neil Gregory Almstead sold 881 shares of the business’s stock in a transaction that occurred on Thursday, January 8th. The stock was sold at an average price of $76.45, for a total value of $67,352.45. Following the completion of the sale, the insider owned 115,196 shares […]

Arcellx, Inc. (NASDAQ:ACLX – Get Free Report) insider Christopher Heery sold 6,131 shares of the company’s stock in a transaction dated Monday, January 12th. The stock was sold at an average price of $64.15, for a total value of $393,303.65. Following the completion of the sale, the insider owned 37,068 shares of the company’s stock, […]

Ardelyx, Inc. (NASDAQ:ARDX – Get Free Report) insider Laura Williams sold 50,000 shares of the business’s stock in a transaction dated Thursday, January 8th. The stock was sold at an average price of $6.98, for a total transaction of $349,000.00. Following the completion of the sale, the insider directly owned 361,563 shares of the company’s […]

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Free Report) EVP Shannon Devers sold 44,199 shares of the firm’s stock in a transaction on Wednesday, January 7th. The stock was sold at an average price of $85.08, for a total value of $3,760,450.92. Following the completion of the sale, the executive vice president owned 17,494 shares of […]

Okta, Inc. (NASDAQ:OKTA – Get Free Report) insider Larissa Schwartz sold 1,899 shares of the company’s stock in a transaction on Wednesday, January 7th. The stock was sold at an average price of $90.74, for a total value of $172,315.26. Following the transaction, the insider directly owned 38,164 shares in the company, valued at approximately […]

Corcept Therapeutics Incorporated (NASDAQ:CORT – Get Free Report) insider William Guyer sold 20,000 shares of the stock in a transaction that occurred on Tuesday, January 6th. The stock was sold at an average price of $35.18, for a total value of $703,600.00. Following the completion of the transaction, the insider owned 1,235 shares of the […]

Insmed, Inc. (NASDAQ:INSM – Get Free Report) insider Michael Alexander Smith sold 1,396 shares of the company’s stock in a transaction that occurred on Tuesday, January 6th. The stock was sold at an average price of $173.33, for a total transaction of $241,968.68. Following the completion of the sale, the insider directly owned 58,799 shares […]

PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report) insider Eric Pauwels sold 1,352 shares of PTC Therapeutics stock in a transaction that occurred on Wednesday, January 7th. The shares were sold at an average price of $77.48, for a total transaction of $104,752.96. Following the sale, the insider owned 87,489 shares of the company’s stock, […]

Intellia Therapeutics, Inc. (NASDAQ:NTLA – Get Free Report) EVP Birgit Schultes sold 8,508 shares of the business’s stock in a transaction that occurred on Monday, January 5th. The shares were sold at an average price of $9.21, for a total transaction of $78,358.68. Following the completion of the sale, the executive vice president directly owned […]

Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) insider Derek Maetzold sold 1,339 shares of the stock in a transaction dated Tuesday, January 6th. The stock was sold at an average price of $40.10, for a total transaction of $53,693.90. Following the completion of the transaction, the insider directly owned 29,513 shares of the company’s […]

Travere Therapeutics, Inc. (NASDAQ:TVTX – Get Free Report) insider Jula Inrig sold 2,031 shares of Travere Therapeutics stock in a transaction on Monday, January 5th. The stock was sold at an average price of $40.18, for a total transaction of $81,605.58. Following the transaction, the insider directly owned 86,756 shares in the company, valued at […]

Spyre Therapeutics, Inc. (NASDAQ:SYRE – Get Free Report) CEO Cameron Turtle sold 15,000 shares of the business’s stock in a transaction that occurred on Friday, January 2nd. The shares were sold at an average price of $30.68, for a total transaction of $460,200.00. Following the transaction, the chief executive officer owned 671,907 shares of the […]

Sight Sciences, Inc. (NASDAQ:SGHT – Get Free Report) insider Jeremy Hayden sold 9,385 shares of Sight Sciences stock in a transaction that occurred on Monday, January 5th. The shares were sold at an average price of $7.82, for a total transaction of $73,390.70. Following the sale, the insider owned 247,205 shares of the company’s stock, […]

PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report) VP Mark Elliott Boulding sold 2,266 shares of PTC Therapeutics stock in a transaction on Monday, January 5th. The shares were sold at an average price of $75.55, for a total value of $171,196.30. Following the completion of the sale, the vice president directly owned 120,901 shares […]

Galectin Therapeutics Inc. (NASDAQ:GALT – Get Free Report) CFO Jack Callicutt sold 20,354 shares of the stock in a transaction dated Tuesday, January 6th. The shares were sold at an average price of $3.67, for a total transaction of $74,699.18. Following the transaction, the chief financial officer owned 7,614 shares of the company’s stock, valued […]

Maze Therapeutics, Inc. (NASDAQ:MAZE – Get Free Report) SVP Amy Bachrodt sold 5,000 shares of the business’s stock in a transaction on Friday, January 2nd. The shares were sold at an average price of $39.15, for a total transaction of $195,750.00. Following the sale, the senior vice president owned 12,965 shares of the company’s stock, […]

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Get Free Report) insider James Hamilton sold 40,164 shares of the firm’s stock in a transaction that occurred on Monday, January 5th. The shares were sold at an average price of $63.11, for a total transaction of $2,534,750.04. Following the transaction, the insider directly owned 171,958 shares in the company, […]

Etsy, Inc. (NASDAQ:ETSY – Get Free Report) insider Josh Silverman sold 86,666 shares of the business’s stock in a transaction on Friday, January 2nd. The stock was sold at an average price of $57.46, for a total value of $4,979,828.36. Following the completion of the transaction, the insider owned 90,661 shares of the company’s stock, […]

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Get Free Report) insider Sarah Gheuens sold 2,932 shares of the company’s stock in a transaction dated Tuesday, December 30th. The shares were sold at an average price of $27.09, for a total transaction of $79,427.88. Following the transaction, the insider directly owned 64,795 shares of the company’s stock, valued […]

Janux Therapeutics, Inc. (NASDAQ:JANX – Get Free Report) insider Thomas Diraimondo sold 2,505 shares of the business’s stock in a transaction dated Friday, January 2nd. The shares were sold at an average price of $13.73, for a total value of $34,393.65. Following the completion of the transaction, the insider owned 124,425 shares in the company, […]

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Get Free Report) insider James William Burns sold 2,932 shares of the business’s stock in a transaction on Tuesday, December 30th. The shares were sold at an average price of $27.09, for a total value of $79,427.88. Following the completion of the sale, the insider directly owned 31,718 shares in […]